Financials
Financial year 2025
IMMUNOVACC CONSULTING from Mont-Saint-Guibert, company number BE0830009006, closed financial year 2025 with a result of € 16,585 after tax. For that financial year IMMUNOVACC CONSULTING recorded a gross margin of € 34,052 and equity of € 273,503. Compared with financial year 2024, the result moved from € 33,463 to € 16,585. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 11, 2026.
€ 273,503
▲ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 16,585
▼ 50% vs 2024
Profit after tax over the fiscal year.
€ 205,866
▲ 16% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 267,303.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 40,121
▼ 6% vs 2024
Of which on lease € 39,922.
Debts at end 2025
€ 25,324
Loans from banks and other lenders, long and short.
€ 1,482
▲ 230% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 13,420
▼ 33% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 39,014 | € 31,557 | € 55,168 | € 34,052 | ▼ 38% |
| Profit after taxes | € 12,909 | € 14,126 | € 33,463 | € 16,585 | ▼ 50% |
| Equity | € 209,328 | € 223,455 | € 256,918 | € 273,503 | ▲ 6% |
| Total debts | € 43,604 | € 36,120 | € 45,837 | € 40,226 | ▼ 12% |
| Cash | € 129,384 | € 153,419 | € 177,728 | € 205,866 | ▲ 16% |
| Retained profit | € 203,128 | € 217,255 | € 250,718 | € 267,303 | ▲ 7% |
| Bank debt | € 30,667 | € 27,995 | € 25,324 | € 25,324 | |
| Balance sheet total | € 252,932 | € 259,575 | € 302,754 | € 313,729 | ▲ 4% |
Key figures of IMMUNOVACC CONSULTING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to IMMUNOVACC CONSULTING?
What happened at IMMUNOVACC CONSULTING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 16,585 (▼ 50% vs 2024). filed late Source: NBB ↗
- New establishment in Ukkel. KBO
- Start of the company according to the CBE. KBO
In short
From € 12,909 profit in 2022 to € 16,585 profit in 2025.
Paid € 34,040 in corporate taxes since 2022.
Best year ever: 2024, with € 33,463 profit.
A new publication or filing at IMMUNOVACC CONSULTING? We notify you, reason included.
Follow IMMUNOVACC CONSULTINGDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind IMMUNOVACC CONSULTING is Patrice DUBOIS.
Directors
According to the 2025 annual accounts
Patrice DUBOIS
Director
Establishments
Establishment units
Physical locations of this company
Rue des Tilleuls 24
1435 Mont-Saint-Guibert
Colonel Chaltinstraat 49 box 5
1180 Ukkel
Active since 6 October 2010
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0830.009.006
- VAT number
- BE 0830.009.006
- Registered office
- Rue des Tilleuls 24, 1435 Mont-Saint-Guibert
- Names & denominations
- IMMUNOVACC CONSULTING
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 October 2010
- Peppol
- Active · Active since 19 Dec 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied